Tag: FDA biosimilars
22Nov
Lot-to-Lot Variability in Biologics and Biosimilars: What You Need to Know
Lot-to-lot variability is normal in biologics and biosimilars due to their complex biological production. Unlike generics, biosimilars aren't exact copies but are proven safe and effective despite natural variations between batches.